-DOCSTART- -X- O
Several -X- _ O
studies -X- _ O
have -X- _ O
shown -X- _ O
that -X- _ O
cell-mediated -X- _ O
immune -X- _ O
responses -X- _ O
play -X- _ O
a -X- _ O
crucial -X- _ O
role -X- _ O
in -X- _ O
controlling -X- _ O
viral -X- _ O
replication. -X- _ O
As -X- _ O
such -X- _ O
, -X- _ O
a -X- _ O
candidate -X- _ B-Intervention
SARS -X- _ I-Intervention
vaccine -X- _ I-Intervention
should -X- _ O
elicit -X- _ O
broad -X- _ O
CD8+ -X- _ O
T-cell -X- _ O
immune -X- _ O
responses. -X- _ O
Several -X- _ B-Patient
groups -X- _ I-Patient
of -X- _ I-Patient
mice -X- _ I-Patient
were -X- _ O
immunized -X- _ B-Comparison
alone -X- _ I-Comparison
or -X- _ O
in -X- _ B-Intervention
combination -X- _ I-Intervention
with -X- _ I-Intervention
SARS- -X- _ I-Intervention
nucleocapsid -X- _ I-Intervention
immunogen. -X- _ I-Intervention
A -X- _ O
high -X- _ B-Outcome
level -X- _ I-Outcome
of -X- _ I-Outcome
specific -X- _ I-Outcome
SARS-CD8+ -X- _ I-Outcome
T-cell -X- _ I-Outcome
response -X- _ I-Outcome
was -X- _ I-Outcome
demonstrated -X- _ I-Outcome
in -X- _ O
mice -X- _ B-Patient
that -X- _ O
received -X- _ O
DNA -X- _ B-Intervention
encoding -X- _ I-Intervention
the -X- _ I-Intervention
SARS-nucleocapsid -X- _ I-Intervention
, -X- _ I-Intervention
protein -X- _ I-Intervention
and -X- _ I-Intervention
XIAP -X- _ I-Intervention
as -X- _ I-Intervention
an -X- _ I-Intervention
adjuvant. -X- _ I-Intervention
We -X- _ O
also -X- _ O
observed -X- _ O
that -X- _ O
co-administration -X- _ O
of -X- _ O
a -X- _ O
plasmid -X- _ B-Intervention
expressing -X- _ I-Intervention
nucleocapsid -X- _ I-Intervention
, -X- _ I-Intervention
recombinant -X- _ I-Intervention
protein -X- _ I-Intervention
and -X- _ I-Intervention
montanide -X- _ I-Intervention
/ -X- _ I-Intervention
CpG -X- _ I-Intervention
induces -X- _ B-Outcome
high -X- _ I-Outcome
antibody -X- _ I-Outcome
titers -X- _ I-Outcome
in -X- _ O
immunized -X- _ B-Patient
mice. -X- _ I-Patient
Moreover -X- _ O
, -X- _ O
this -X- _ O
vaccine -X- _ O
approach -X- _ O
merits -X- _ O
further -X- _ O
investigation -X- _ O
as -X- _ O
a -X- _ O
potential -X- _ O
candidate -X- _ O
vaccine -X- _ O
against -X- _ O
SARS -X- _ O
. -X- _ O

